A concise flow synthesis of efavirenz.

Efavirenz is an essential medicine for the treatment of HIV, which is still inaccessible to millions of people worldwide. A novel, semi-continuous process provides rac-Efavirenz with an overall yield of 45%. This streamlined proof-of-principle synthesis relies on the efficient copper-catalyzed formation of an aryl isocyanate and a subsequent intramolecular cyclization to install the carbamate core of Efavirenz in one step. The three-step method represents the shortest synthesis of this life-saving drug to date.

[1]  Yihua Zhang,et al.  Synthesis of Aryl Carbamates via Copper‐Catalyzed Coupling of Aryl Halides with Potassium Cyanate , 2012 .

[2]  Jun-ichi Yoshida,et al.  Generation and reactions of o-bromophenyllithium without benzyne formation using a microreactor. , 2007, Journal of the American Chemical Society.

[3]  Timothy F. Jamison,et al.  Continuous flow multi-step organic synthesis , 2010 .

[4]  Julian Tirado-Rives,et al.  Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulations. , 2002, Journal of medicinal chemistry.

[5]  James R. Moore,et al.  Practical asymmetric synthesis of Efavirenz (DMP 266), an HIV-1 reverse transcriptase inhibitor , 1998 .

[6]  Diego Ghislieri,et al.  Chemische Fertigungssysteme: Kontrolle auf mehreren Ebenen für die divergente, kontinuierliche und vielstufige Synthese von pharmazeutisch aktiven Wirkstoffen , 2015 .

[7]  Jun-ichi Yoshida,et al.  Flash chemistry: flow microreactor synthesis based on high-resolution reaction time control. , 2010, Chemical record.

[8]  Steven V Ley,et al.  Flow chemistry syntheses of natural products. , 2013, Chemical Society reviews.

[9]  A. Kirschning,et al.  Multiple Organolithium Generation in the Continuous Flow Synthesis of Amitriptyline , 2013 .

[10]  Peter H Seeberger,et al.  Chemical assembly systems: layered control for divergent, continuous, multistep syntheses of active pharmaceutical ingredients. , 2014, Angewandte Chemie.

[11]  James R. Moore,et al.  In situ recycling of chiral ligand and surplus nucleophile for a noncatalytic reaction: Amplification of process throughput in the asymmetric addition step of efavirenz (DMP 266) , 2003 .

[12]  Mohammad Hadi Baghersad,et al.  Copper-Catalyzed Coupling of Arylboronic Acids with Potassium Cyanate: A New Approach to the Synthesis of Aryl Carbamates , 2011 .

[13]  Ian W Davies,et al.  Looking Forward in Pharmaceutical Process Chemistry , 2009, Science.

[14]  Flavien Susanne,et al.  Continuous flow synthesis. A pharma perspective. , 2012, Journal of medicinal chemistry.

[15]  J. Yoshida,et al.  Three-component coupling based on flash chemistry. Carbolithiation of benzyne with functionalized aryllithiums followed by reactions with electrophiles. , 2014, Journal of the American Chemical Society.

[16]  Gary S. Calabrese,et al.  From batch to continuous flow processing in chemicals manufacturing , 2011 .

[17]  Timothy F. Jamison,et al.  End-to-end continuous flow synthesis and purification of diphenhydramine hydrochloride featuring atom economy, in-line separation, and flow of molten ammonium salts , 2013 .

[18]  Duncan Guthrie,et al.  Continuous Flow-Processing of Organometallic Reagents Using an Advanced Peristaltic Pumping System and the Telescoped Flow Synthesis of (E/Z)-Tamoxifen , 2013 .

[19]  James M. B. Evans,et al.  End-to-end continuous manufacturing of pharmaceuticals: integrated synthesis, purification, and final dosage formation. , 2013, Angewandte Chemie.

[20]  Jun-ichi Yoshida,et al.  Flash chemistry: flow chemistry that cannot be done in batch. , 2013, Chemical communications.

[21]  Steven V Ley,et al.  An expeditious synthesis of imatinib and analogues utilising flow chemistry methods. , 2013, Organic & biomolecular chemistry.

[22]  Tomas Gustafsson,et al.  Development of a Continuous Flow Scale-Up Approach of Reflux Inhibitor AZD6906 , 2012 .

[23]  Nathaniel H. Park,et al.  Palladium-catalyzed synthesis of N-aryl carbamates. , 2013, Organic letters.

[24]  S Diamond,et al.  Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. , 2000, Journal of medicinal chemistry.

[25]  Andreas Seidel-Morgenstern,et al.  Continuous synthesis of artemisinin-derived medicines. , 2014, Chemical communications.

[26]  D Ross-Degnan,et al.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis , 2009, The Lancet.

[27]  James R. Moore,et al.  Synthesis of HIV-1 Reverse Transcriptase Inhibitor DMP 266 , 1997 .